These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8837458)

  • 41. [The effect of cysteamine on the duodenal defense mechanism in the vagotomized rats--with special reference to the parietal cell vagotomy with CO2-laser].
    Kadota T
    Nihon Geka Gakkai Zasshi; 1983 Nov; 84(11):1155-60. PubMed ID: 6674774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating γ-glutamylcysteine synthetase.
    Choi KS; Kim EH; Hong H; Ock CY; Lee JS; Kim JH; Hahm KB
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():13-22. PubMed ID: 22486866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids.
    Jayaraj AP; Tovey FI; Lewin MR; Clark CG
    J Gastroenterol Hepatol; 2000 Jun; 15(6):610-6. PubMed ID: 10921413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The site (central or peripheral) of the anti-ulcer action of dalargin, a synthetic analog of endogenous opioids in an experimental model of cysteamine-induced duodenal ulcer in rats].
    Polonskiĭ VM; Iarygin KN; Krivosheev OG; Moskovkin GN; Vinogradov VA
    Biull Eksp Biol Med; 1987 Apr; 103(4):433-4. PubMed ID: 3032303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers in rats.
    Kunizaki C; Sugiyama M; Tsuchiya S
    Scand J Gastroenterol Suppl; 1989; 162():218-21. PubMed ID: 2595299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers.
    Khomenko T; Szabo S; Deng X; Jadus MR; Ishikawa H; Osapay K; Sandor Z; Chen L
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1211-8. PubMed ID: 16484680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from that of cimetidine.
    Morimoto Y; Shimohara K; Tanaka K; Hara H; Sukamoto T
    Jpn J Pharmacol; 1994 Mar; 64(3):221-4. PubMed ID: 8022123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duodenal ulcers are associated with a depletion of duodenal calcitonin gene-related peptide-like immunoreactivity in rats.
    Evangelista S; Renzi D; Mantellini P; Surrenti C; Meli A
    Eur J Pharmacol; 1989 May; 164(2):389-91. PubMed ID: 2788098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The anti-ulcer action of zinc sulfate in models of acute and chronic ulcerogenesis in the rat duodenum].
    Trapkov VA; Gobedzhashvili OD; Erzinkian KL
    Eksp Klin Farmakol; 1996; 59(6):26-8. PubMed ID: 9181867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duodenal ulcerogens, cysteamine and propionitrile, stimulate serum gastrin levels in the rat.
    Lichtenberger LM; Szabo S; Trier JS
    Gastroenterology; 1977 Dec; 73(6):1305-8. PubMed ID: 913972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pirenzepine prevents cysteamine-induced formation of gastroduodenal ulcers and reduction of mesenteric circulation.
    Bernardini MC; Blandizzi C; Morini G; Chiavarini M; Impicciatore M; Del Tacca M
    Arch Int Pharmacodyn Ther; 1989; 302():242-54. PubMed ID: 2636820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glutathione and ascorbic acid concentrations in the duodenum of rats with cysteamine-induced ulcers: influence of cysteine and ascorbic acid pretreatments.
    Ali BH; Abdel Gayoum AA; Bashir AA; el-Fakhri M
    Pharmacology; 1990; 40(5):258-64. PubMed ID: 2274572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biliary and pancreatic secretions influence experimental duodenal ulcer without affecting gastric secretion in the rat.
    Pihan G; Gallagher GT; Szabo S
    Dig Dis Sci; 1985 Mar; 30(3):240-6. PubMed ID: 3918841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cysteamine-induced duodenal ulcer is not site-specific: effect of local modulating factors.
    Adler RS; Nafradi J; Szabo S
    J Exp Pathol; 1985; 2(2):111-22. PubMed ID: 3842391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cysteamine-induced duodenal ulcer: effects on calcium absorption across rat duodenum.
    Nassar CF; Halabi OH; Jurjus AR; Habbal ZM
    Comp Biochem Physiol A Comp Physiol; 1987; 86(1):103-7. PubMed ID: 2881641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Role of endogenous basic fibroblast growth factor in experimental duodenal ulcer].
    Sándor Z; Kusstatscher S; Sakoulas G; Szabó S
    Orv Hetil; 1995 Jul; 136(28):1501-3. PubMed ID: 7637967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of bile salts in cysteamine-induced duodenal ulcer in the rat and the ulceroprotective property of lysolecithin.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():116-20. PubMed ID: 6588495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
    Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
    Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.